Related Articles
Moderate dose-intensive chemotherapy for patients with non-small cell lung cancer: randomized trial, can it improve survival of patients with good performance status?
Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study.
LIMITED SMALL-CELL LUNG-CARCINOMA - HIGH COMPLETE RESPONSE RATE AND SURVIVAL WITH SHORT INTENSIVE CHEMOTHERAPY AND EXTENSIVE IRRADIATION - RESULTS OF A PILOT-STUDY
RANDOMIZED TRIAL COMPARING ADRIAMYCIN VINCRISTINE (AV) CYCLOPHOSPHAMIDE METHOTREXATE 5-FLUOROURACIL PREDNISONE (CMFP) HYBRID VERSUS AV-CMFP MONTHLY ALTERNATED IN METASTATIC BREAST-CANCER
MITOXANTRONE, ETOPOSIDE AND BLEOMYCIN (MEB) CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA PATIENTS NON-ELEGIBLE FOR STANDARD CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) COMBINATION